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Introduction
Generation of Growth Hormone Reporter Gene Constructs cPLA 2 γ promoter fragments were amplified from bacterial artificial chromosome clones generously provided by the Wellcome Trust Sanger Institute using primers described in Supplementary Table 2 . Amplified fragments were cloned into the TOPO-XL vector (Invitrogen), HindIII digested, and cloned into a HindIII digested promoterless growth hormone reporter plasmid (pØGH) [22] . The -114/-1 promoter was generated by site-directed deletion with the Quikchange® Site-Directed Mutagenesis Kit (Stratagene) from the -114/+174 fragment in pØGH according to the manufacturer's instructions . The heterologous viral thymidine kinase (TK) promoter was coupled to the hGH reporter gene to create a pTKGH vector as previously described [23] . pTKGH constructs were generated by inserting the -114/-1 fragment into a HindIII restriction site upstream of the TK promoter in the forward and reverse orientations. All constructs were verified by DNA sequencing.
Cell Culture RNA Isolation, Northern Analysis and Real-time RT-PCR
Total RNA was isolated as previously described [18] with the following modifications. Following guanidinium thiocyanate-phenol-chloroform extraction, cell lysates were precipitated at -20 °C for 30 min with isopropanol and the resulting pellets were resuspended in RNase-free water. LiCl was then added to a final concentration of 2 M. The tubes were again placed at -20 °C for 30 min, centrifuged for 20 min at 4 °C, rinsed with ethanol, dried and resuspended in RNase-free water prior to determination of concentration by UV spectrophotometry. Five μg of total RNA was fractionated on a 1% formaldehyde/agarose gel and electrotransferred to charged nylon membranes. The membranes were then probed for the indicated mRNA with a 32 P-radiolabeled probe and exposed to Hyperfilm™ MP (GE Healthcare) as previously described [24] . Densitometry was quantified from X-ray films using the ImageJ program (NIH). Data points are the means from at least three independent experiments. For realtime RT-PCR analysis, total RNA was isolated from transfected cells using an RNeasy Mini Kit (Qiagen), with reverse transcription and real-time PCR performed as described above.
Immunoblot Analysis
Protein was collected and subjected to immunoblot analysis as previously described [25] . Briefly, protein was isolated from treated cells in lysis buffer containing Complete Mini protease inhibitor (Roche) and the protein concentration was determined by a BCA assay (Pierce). 20 μg of protein was separated on a 7.5% Tris-HCl Ready-Gel (Bio-Rad) and electrotransferred to a Trans-Blot® (Bio-Rad) charged nitrocellulose membrane. Membranes were then stained with Ponceau S (Sigma/Aldrich) to verify even loading. After blocking, membranes were probed with antibodies to cPLA 2 γ (kind gift from Christina Leslie) or β-actin. Probed membranes were subjected to ECL™ (GE Healthcare) and visualized by exposure to Hyperfilm™ MP (GE Healthcare). Densitometry was quantified from X-ray films using the ImageJ program (NIH).
Chromatin Immunoprecipitation (ChIP)
ChIP analysis was performed as previously described [25] . Briefly, S9 cells were treated with 10 ng/mL of TNF for 12 h prior to formaldehyde crosslinking. Immunoprecipitation without antibody (noAb) or with nonspecific IgG were used as controls alongside antibodies for c-Jun, ATF-2, p65, p50, USF1, USF2, or RNA Polymerase II (Santa Cruz). Following immunoprecipitation and purification, samples were subjected to real-time PCR analysis using primers for the cPLA 2 γ promoter/enhancer and a nonspecific control region for the cPLA 2 γ 3'UTR (Supplementary Table 2 ). All values are graphed as a fraction of the total isolated chromosomal DNA (input) prior to immunoprecipitation. Only values above those of baseline IgG were considered relevant.
Transcription Factor Overexpression
Overexpression of transcription factor proteins or their respective dominant negative forms was performed using a mammalian expression plasmid containing the coding region for the following transcription factors: c-Jun, p65 (kind gift from Dr. Mary E. Law), ATF-2 (kind gift from Dt. Alt Zantema), or USF1 (kind gift from Dr. Jörg Bungert) or the dominant negative forms: c-Jun/Tam67, p65/ΔTA (kind gift from Dr. Mary E. Law), ATF-2/A-ATF2 (kind gift from Dr. Charles Vinson) [26], or USF/A-USF (kind gift from Dr. Vinson) [27] . These plasmids were cotransfected, with the cPLA 2 γ -114/-1 fragment in pØGH, as described above. 48 h post-transfection, RNA was isolated, DNase I treated and subjected to real-time RT-PCR analysis as described above. The fold induction was calculated relative to cells transfected with the cPLA 2 γ enhancer/promoter hGH reporter construct and an empty mammalian expression vector (pcDNA3.1) without transcription factors (no TF) normalized to 1.
Statistical Analysis
Statistical analyses were determined by an unpaired Student's t-test to a p value ≤ 0.05 for all experiments. A two-tailed Student's t-test was performed for the animal and cell culture overexpression studies. A c c e p t e d M a n u s c r i p t Licenced copy. Copying is not permitted, except with prior permission and as allowed by law.
Results

Gene Expression of the Phospholipase A 2 s
Our previous report demonstrated that Af-sensitized mice develop a T h 2 mediated response typical of asthma as indicated by increases in total serum IgE, goblet cell hyperplasia and airway eosinophilia [8] . Having established a physiologically and environmentally relevant asthmatic model, we proceeded to evaluate changes in phospholipase gene expression in tissue from lavaged lungs as a consequence of Af-induced asthma. The gene expression levels for a subset of the sPLA 2 s were evaluated by real-time RT-PCR ( Fig. 1A) . Only Pla2g2e and Pla2g5 levels were increased in the Af sensitized/challenged animals. In contrast, Af resulted in a ~50% reduction in the basal expression of Pla2g12b. We next evaluated the expression levels of three members of the PLA 2 group IV family, Pla2g4a, Pla2g4b, and Pla2g4c. Interestingly, the expression levels for Pla2g4a and Pla2g4b remained unchanged, while the relative expression of Pla2g4c increased dramatically (~35 fold) in Af sensitized/challenged mice ( Fig. 1B) .
Evaluation of Pla2g4c/cPLA 2 γ Expression in Immune and Parenchymal Lung Cells
We therefore sought to further evaluate the molecular mechanisms regulating Pla2g4c, which will be henceforth referred to as cPLA 2 γ, in relationship to our allergen-induced asthma model. We previously noted that eosinophils composed ~70% of cells in the BALs in sensitized/ challenged C57BL/6J mice [8] . Therefore, we first analyzed the expression of cPLA 2 γ in a human eosinophilic leukemia cell line, EoL-1 [21]. Additionally, several components of Af are ligands for the toll-like receptors [28], many of which are constitutively expressed in eosinophils. Figure 2A illustrates that cPLA 2 γ expression levels are increased up to 15 fold in response to increasing concentrations of Af extract in EoL-1 cells. In contrast, cPLA 2 γ mRNA levels were unchanged after Af exposure in a human bronchial epithelial-derived cell line, S9 [20] ( Fig. 2A) .
To determine which other cell types or downstream signaling events in the lung could be contributing to the overall induction seen in whole lungs from our mouse model, primary mouse alveolar macrophages were exposed to Af extract. Interestingly, primary alveolar macrophages exposed to Af extract did not exhibit an increase in cPLA 2 γ mRNA levels (data not shown), however we did observe changes in secreted levels of specific cytokines and chemokines ( Fig. 2B ). IFNγ, TNF, IL-6, IL-10, and the immune cell-specific chemokines, MCP1 and MIP-1α, were elevated, providing potential insight into the robust induction of cPLA 2 γ seen in whole lungs. Based on this finding, cPLA 2 γ mRNA levels were then evaluated in S9 cells treated with LPS, IFNγ, TNF and a variety of interleukins ( Fig. 2C ). Only TNF and IL-1β were capable of inducing cPLA 2 γ mRNA in this parenchymal cell line, with the most potent activation elicited by TNF (>6 fold) ( Fig. 2C ). We also investigated this response in two additional human lung-derived cell lines, A549 (epithelial-like adenocarcinoma) and HFL-1 (human fetal lung fibroblast), with cPLA 2 γ mRNA induced in each of these cell lines, although the largest induction was still observed in the S9 cells ( Fig. 2D ). Furthermore, Figure 2E illustrates a representative immunoblot (top) and corresponding densitometry (bottom), confirming that cPLA 2 γ protein levels are commensurately elevated by 3 fold, 24 h following TNF exposure in S9 cells.
It has previously been demonstrated that TNF plays a critical role in asthma progression in response to ovalbumin in mice [29] . Lindbom et al. [30] have demonstrated an increase in cPLA 2 γ mRNA by TNF in lung epithelial cells. Based on these studies, we believe that macrophage derived TNF may be the common link between observations in the animal model of Af-induced asthma and the induction of cPLA 2 γ in the S9 bronchoepithelial cells. To further characterize the temporal pattern of this induction, human S9 cells were exposed to TNF for increasing durations, displaying a statistically significant induction of the steady-state mRNA by 4 h (Fig. 2F ). An increase in steady-state mRNA levels may be a result of de novo transcription of the gene or due to increased stability of the mRNA transcript. Analogous to a nuclear run-on, we utilized real-time RT-PCR of heterogeneous nuclear RNA (hnRNA) [24] to determine the level of contribution of de novo transcription. These results demonstrate that hnRNA levels are rapidly induced within 30 min and become maximal at 1 h (~9 fold) ( Fig. 2F ).
Identification of a TNF responsive region controlling cPLA 2 γ gene expression
We next sought to identify the regulatory sequences responsible for TNF-mediated induction. The structure of the human cPLA 2 γ gene derived from the Wellcome Trust Sanger Institute (www.sanger.ac.uk) is displayed in Figure 3A . The human mRNA is 2581 bp in length and comprises 17 exons spanning over 60,000 bp. The promoter region of the cPLA 2 γ gene is expanded in Figure 3A depicting the fragments utilized for promoter deletion analyses from a human cPLA 2 γ BAC clone and subcloned into a human growth hormone (hGH) reporter plasmid [22] . To evaluate the functionality and cytokine-responsiveness of these promoters, each construct was transiently transfected into S9 cells. To control for transfection efficiency, S9 cells were batch transfected with each construct, exposed to TNF and hGH expression evaluated by northern analysis. Following incubation with IL-1β or TNF, total cellular RNA was extracted and hGH reporter gene expression evaluated by northern analysis and densitometry ( Fig. 3A) . It was determined that cytokine-responsive sequences reside within the 1.3 kb promoter fragment and that TNF clearly elicits the most significant induction (Fig. 3B ). The TNF response requires sequences from -114 to +174 relative to the transcriptional start site ( Fig. 3C ). To determine the relevance of the 174 bp exonic sequence, we also studied a fragment from -114/-1, which demonstrated a lower but significant TNF-dependent induction ( Fig. 3D ), with no statistically significant difference between the two constructs. In addition to the ability of this region to function as a promoter, we tested this fragment's function as a stimulus-dependent enhancer. Constructs were generated by coupling the -114/-1 fragment in the forward and reverse orientation to a minimal viral thymidine kinase (TK) promoter that exhibits low level expression in most cell types. This fragment was able to drive the heterologous TK promoter in an orientation-independent manner, satisfying the definition of a stimulusspecific enhancer element ( Fig. 3E ).
We next sought to identify potential regulatory factor binding sequences within the -114/-1 enhancer/promoter fragment. The consensus sites for CRE, NF-κB and a potential E-box were identified using the TESS software (www.cbil.upenn.edu/cgi-bin/tess/tess) based on the TRASFAC database [31]. The potential regulatory factor consensus binding sites are underlined in Figure 4A along with the sites which were subsequently deleted in black italicized text. Northern and real-time RT-PCR analyses demonstrate that deletion of the respective binding sites inhibits the TNF-mediated induction to varying degrees, with the deletions of the CRE and NF-κB sites having the most pronounced effect ( Fig. 4B , C).
ATF-2, c-Jun, p65/RelA, USF1 and USF2 as Cognate Regulatory Factors Binding the cPLA 2 γ
Enhancer/Promoter by ChIP Analysis
To determine the cognate transcription factors in the endogenous chromatin environment that may bind the respective enhancer/promoter consensus binding elements, we employed chromatin immunoprecipitation (ChIP) analysis. Two structurally and functionally related protein families have been associated with CRE sites, Jun and ATF [32]. ATF-2/c-Jun heterodimers have been identified previously, such as in the well-studied IFN-β [33] and TNF enhancers, the latter of which also responds to TNF [34] . We next evaluated the potential interaction of c-Jun and ATF-2 with primers flanking the -114/-1 enhancer/promoter in response to 12 h of TNF treatment by ChIP analysis (Fig. 5A ). We utilized three controls in our ChIP studies to ensure the specificity of the results: no antibody (noAb), nonspecific IgG (IgG) and ChIP analysis of a downstream 3' untranslated region (3'UTR) of the cPLA 2 γ gene. The data demonstrate the inducible association of both ATF-2 and c-Jun with the enhancer/promoter region as compared to the 3'UTR or other control samples (Fig. 5A ). The NF-κB consensus element can be occupied by a family of transcription factors, including p50, p52, p65 (RelA), c-Rel and RelB [35] . The results with p65/RelA-specific ChIP clearly demonstrate that p65 inducibly binds to the human cPLA 2 γ enhancer/promoter region following 12 h of TNF treatment (Fig. 5B) . The E-box sequence (5'-CANNTG-3') is bound by a repertoire of cognate factors, including the upstream stimulating factors (USF1 and 2). USF1 and 2 proteins are ubiquitously expressed and function as transcriptional activators, through interaction with members of the pre-initiation complex as well as in the recruitment of chromatin remodeling enzymes [36] . ChIP analysis demonstrated specific interaction of USF1 and 2 with the cPLA 2 γ enhancer/promoter region following 12 h of TNF stimulation (Fig. 5C ). It should be noted that USF1 and USF2 function almost exclusively as a heterodimeric complex [37] , which is supported by our ChIP results.
We next sought to determine if there was a temporal ordered recruitment of these factors following stimulation. We performed similar ChIP analyses at 15, 30 and 60 min ( Fig. 6 ). RNA Polymerase II is recruited to the enhancer/promoter within 15 min of stimulation with TNF, as were p65 and USF1 (Figs. 6A-C). We also tested p50, the prominent binding partner for p65, and found no detectable association of p50 with the enhancer/promoter up to 60 min after stimulation ( Fig. 6B ). Interestingly, neither ATF-2 nor c-Jun showed a statistically significantly inducible association with the enhancer/promoter region up to two hours, although there does appear to be an upward trend of ~2 fold above baseline IgG levels 1-2 h following TNF stimulation ( Fig. 6D ).
Functional relevance of ATF-2, c-Jun, p65, USF: Overexpression and Dominant Negative Analyses
To establish the functional relevance of these transcription factors to human cPLA 2 γ gene regulation, we cotransfected S9 cells with each individual transcription factor and the cPLA 2 γ enhancer/promoter hGH reporter construct ( Fig. 7A ). Real-time RT-PCR demonstrates the ability of c-Jun, p65 or USF1 alone to drive expression from the cPLA 2 γ enhancer/promoter, with no statistically significant response to ATF-2 ( Fig. 7A ). To further investigate the roles of these factors, we next utilized dominant negative forms of each factor lacking activation domains: c-Jun/Tam67, ATF-2/A-ATF2, p65/ΔTA, and USF/A-USF. The dominant negative USF/A-USF has been shown to inhibit function of both USF1 and USF2 [27] . We observed a small but statistically significant inhibition of TNF stimulation with c-Jun/Tam67 and USF/A-USF (1.6 and 1.8 fold, respectively), relative to the 3.6 fold observed in the control with no transcription factor transfection ( Fig. 7B ). However, p65/ΔTA completely blocked TNF induction mediated from the cPLA 2 γ enhancer/promoter ( Fig. 7B ). Interestingly, only ATF-2/A-ATF2 was capable of inhibiting basal activity (>50%), while c-Jun/Tam67 showed an ~2.5 fold increase in basal activity. Our repeated attempts to further delineate the roles of these transcription factors utilizing combinations or individual siRNAs were unsuccessful despite >50% knockdown of the endogenous protein levels (data not shown). This may be a consequence of transcription factor cooperativity/interdependence and/or the close proximity of the CRE, NF-κB and Ebox binding sites ( Fig. 4A) .
To address the cooperation between the subset of factors involved in transcriptional activation, c-Jun, p65, and USF1 ( Fig. 7A ) were coexpressed with specific dominant negatives. We chose to exclude further studies with c-Jun/Tam67 due to its ability to activate transcription in our studies as well as others ( Fig. 7B ) [38] . Overexpression of ATF-2/A-ATF2 and USF/A-USF in combination with p65 caused a >50% inhibition relative to p65 alone ( Fig. 7C) . Similarly, c-Jun overexpression results in a ~3.5 fold induction which is inhibited >50% by coexpression with a dominant negative to its putative heterodimeric binding partner, ATF-2/A-ATF2 ( Fig. 7C ). 
Discussion
Given the recent studies which have linked the ubiquitous fungus, Aspergillus fumigatus (Af), with an increased prevalence in asthmatics [39, 40] , we employed a mouse model which could mimic the pathology of allergen-induced asthma using an Af extract for sensitization/challenge. The metabolic flux through the eicosanoid pathway initially requires the release of AA from membrane phospholipids, so we examined a subset of phospholipase A 2 s in our mouse model (Fig. 1A) . Our observed induction of Pla2g5 correlates with recent studies by the Balestrieri laboratory linking PLA2G5 with the innate response demonstrating its importance in the macrophage response to the phagocytosis of zymosan and Candida albicans [41] as well as in antigen processing and dendritic cell maturation during pulmonary inflammation and the immune response to the house dust mite Dermatophagoides farinae [42] .
To date, most asthma studies have focused primarily on secretory PLA 2 s from sputum samples or cytosolic PLA 2 s in circulating blood. Therefore, we examined RNA from lavaged whole lung for members of the cytosolic group IV PLA 2 s, which have been designated IVA through IVF with the corresponding Greek letters as cPLA 2 α, β, γ, δ, ε and ζ, respectively. These enzymes have been directly linked to the cytosolic liberation of AA as a consequence of the inflammatory response, with the vast majority of studies focused on PLA2G4A [43] . The only phospholipase for which we observed a significant induction was Pla2g4c/cPLA 2 γ (~35 fold) ( Fig. 1B) .
In addition to the present data associating cPLA 2 γ with an allergic T h 2-type effector response, Brown et al. [14] previously demonstrated an analogous induction of this enzyme in the infection of intestinal epithelium by the helminth, Trichinella spiralis. These investigators proposed a major role for cPLA 2 γ in the initiation and propagation of parasite induced allergic inflammation. Our observation that this gene is elevated in an asthma model is novel, with the only other documented connection coming from a study on the secreted group X phospholipase in asthmatic patients where the investigators simply noted the presence of PLA2G4C in sputum cells [44] .
Given the connection of cPLA 2 γ with Af sensitization/challenge and in parasitic infection by Trichinella spiralis [14] , we felt it was physiologically relevant to further evaluate the molecular mechanisms mediating cPLA 2 γ gene regulation in the lung. Our analyses ( Fig. 2A -E) of potential cell types and stimuli in the lung argue that Af extract may induce cPLA 2 γ levels directly in eosinophils and through activation of macrophages leading to TNF secretion, ultimately inducing cPLA 2 γ gene expression in lung fibroblasts and epithelial cells ( Fig. 2D ). Furthermore, we also confirmed the relevance of TNF-dependent induction at both the protein and transcriptional levels ( Fig. 2E and 2F) . Similarly, Lindbom et al.
[30] showed induction of cPLA 2 γ mRNA levels by TNF in RPMI 2650 nasal epithelial cells as well as BEAS-2B bronchoepithelial cells. This observation is consistent with the significant role of TNF in the etiology of severe or refractory asthma with the increased presence of TNF in the airway and peripheral blood mononuclear cells from severe asthmatics [45] . Furthermore, inhalation of recombinant TNF in normal subjects leads to the development of airway hyperresponsiveness and airway neutrophilia [46] , while TNF blockade has been associated with improvement in severe asthma in both mice [47] and humans [48] .
Therefore, to address the importance of TNF-mediated cPLA 2 γ induction, we identified a TNFresponsive regulatory region within 114 bp of the cPLA 2 γ transcriptional initiation site ( Fig. 3A-D) in bronchoepithelial cells. We also demonstrated that this region could function as a stimulus-dependent enhancer based on its function with a heterologous promoter in an orientation independent fashion (Fig.  3E ). Three separate transcription factor consensus sites within the enhancer/promoter, CRE, NF-κB and E-box, identified by in silico analysis, were functionally verified through deletion studies ( Fig. 4 ) and shown to interact with ATF-2/c-Jun, p65 and USF1/USF2, respectively, through ChIP analysis (Fig. 5) . Analogously, p65, ATF-2 and c-Jun have been previously associated with TNF-mediated responses [34, A temporal analysis of regulatory factor occupancy within the enhancer/promoter demonstrated that RNA polymerase II, p65 and USF are found associated with this region within 15 min of TNF stimulation ( Fig. 6A-C) , whereas ATF-2/c-Jun may arrive within two hours (Fig. 6D ). Interestingly, we found no evidence of p50 interaction with the cPLA 2 γ enhancer/promoter (Fig. 6B) , in contrast to the classical NF-κB complex, p65/p50. We therefore hypothesize that the interaction with the NF-κB consensus sequence involves a p65 homodimer complex. Our overexpression studies further functionally link c-Jun, USF1, and, most significantly, p65, with induction of cPLA 2 γ enhancer/promoter activity (Fig. 7A) , while the expression of dominant negative proteins established the central importance of p65 in TNF induction and ATF-2 in basal expression ( Fig 7B) . The functional interdependence of these transcription factors results from four independent observations: 1) our inability to affect the cytokine induction by individual siRNA knockdown, 2) the close proximity of each of the respective consensus sequences (Fig. 4A) , 3) the interaction of six proteins (ATF-2/c-Jun, p65/p65, and USF1/USF2) within ~40 bp or four DNA helical turns, and 4) most relevantly, the coexpression of activators with functional dominant negative proteins (Fig. 7C ). Our current thoughts are that the function of c-Jun is dependent on the presence of ATF-2, given the significant inhibition of c-Jun-dependent induction by the dominant negative ATF-2/A-ATF2 ( Fig. 7C ). Figure 7C also establishes that the function of p65 requires an strong interdependence with both ATF-2 and USF. This is further supported by the close proximity of the flanking ATF-2/c-Jun and USF1/USF2 binding sites to the centrally localized p65 consensus sequence (Fig. 4A) . Interestingly, p65/ΔTA has little to no effect on either the induction by c-Jun or USF1, implying that p65 is dependent on co-habitation with these factors with no reciprocity.
In summary, our results are the first to establish the induction of cPLA 2 γ in a model of allergic asthma. This is a unique finding given the limited number of studies which have addressed this specific group IV phospholipase. We hypothesize that allergen sensitization/challenge mediates the induction of cPLA 2 γ directly in eosinophils and indirectly in pulmonary epithelial and fibroblast cells via TNF elicited through the activation of alveolar macrophages. Our molecular analyses of cPLA 2 γ gene expression have revealed the existence of a TNF-responsive proximal enhancer/promoter element. We have demonstrated inducible association of ATF-2/c-Jun, p65, and USF1/2 complexes to this region along with a cooperative interaction between these transcription factors, thus providing the first comprehensive evaluation of cPLA 2 γ gene regulation in a pathophysiologically relevant context. 
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